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Background: Mormodica charantia is indigenous in tropical and subtropical regions. It is commonly used for its 
medicinal properties including management of measles and lowering blood glucose. Despite wide consumption of its 
aqueous leaf extracts that are prepared and stored under various conditions, their pharmacological activities on the 
heart are yet to be analyzed.   
Objectives: The objective of the study was to show the effect of Momordica charantia aqueous leaf extract stored 
under various conditions on the isolated mammalian heart. 
Methodology: Six healthy rabbits were included in the study. Each rabbit was sacrificed and the heart mounted on 
the Langerndorff apparatus. Baseline rate and force of contraction were taken, after which each of the various 
aqueous leaf extract was administered in increasing doses and changes in rate and force of contraction noted.  Paired  
T-test  and  repeated  measures  ANOVA  were  used  to  test  for  statistical  significance.  P values less than 0.05 
indicated statistical significance. 
Results: A significant (P<0.001) dose depended increase in myocardial rate and force of contraction with the 
administration of the various extract preparations was noted. However,  there  was  a  larger  increase  in  force  as 
compared  to  rate  of  contraction. 
Discussion: Momordica charantia aqueous leaf extract solution stored in various conditions have different dose 
related effects on myocardial contraction. The current study demonstrated a pattern of increase in force and rate of 
contraction after the administration of the various doses of the extracts. 
Keywords: Momordica charantia, various extract, heart. 
Received: August, 2014  
Published: December, 2014 
 
1. Introduction 
Commonly known as ‘bitter gourd’ and locally as 
‘karela’, Mormodica charantia is one of the most 
commonly used herbs because of its medicinal and 
spiritual values. It is widely explored especially in the 
ayurvedic system. Momordica charantia belongs to the 
Cucurbitaceae family. It is a common plant in Africa, 
America, Asia as well as the Caribbean regions. The 
parts of the plant consumed are leaf, roots and fruits.  
Different phenotypes exist. These include the Chinese 
and the Indian phenotypes. The parts of the plant 
consumed are leaves, roots and seeds that are either 
consumed when still fresh or after drying.  
Numerous medicinal gains have been attributed to 
Momordica charantia. Its fruit has been universally used 
as a blood glucose lowering agent as it increases insulin 
sensitivity as well as insulin levels (Chaturvedi, 2011; 
Blum et al, 2011).  Other properties attributed to 
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Mormodica charantia include antimalarial, anti-
hypertensive, anthelminthic (Nadine et al, 2005) anti-
dysmenorrhea and anticancer (Ray et al, 2010; Hiroyuki 
et al, 2004; Puri et al, 2009) that is extensively 
investigated. Tea prepared from Momordica charantia 
leaves is also used in the management of diabetes. 
(Bakare et al, 2010). Additionally, Mormodica charantia 
possesses antiviral properties against chicken pox and 
measles (Nadine et al, 2005). 
Despite its wide medicinal value, Mormodica charantia 
aqueous leaf extract is contraindicated in certain 
physiological conditions such as pregnancy because it 
has been reported to stimulate uterine smooth muscle 
contraction leading to abortion. (Rae 2011; Nadine et al, 
2005). Consequently, it is used as an abortifacient by 
some communities e.g. in the Philippines. (Rae 2011). 
Mormodica charantia leaf contains a wide range of 
biologically active components primarily momordicin I , 
momordicinII, and cucurbitacin B (Majekodunmi et al, 
1990). Mormodicin I, mormodicin II and cucurbitacin B 
possess purgative and cytotoxic properties. Charantin, 
is a steroid saponin with insulin like effect. It is the main 
anti diabetic agent in Mormodica charantia plant. 
(Ernest et al, 2011). Mormodica charantia leaf also 
contains bioactive glycosides including momordin, 
charantosides, glycosides, momordicosides, 
goyaglycosides and other terpenoid compounds that 
include momordicin-28, momordicinin, momordicilin, 
momordenol, and momordol. (Sabira et al, 1997; 
Kimura et al, 2005). The terpenoids are also responsible 
for the anti-diabetic, anti-cancer, anti-obesity and anti-
HIV properties that are attributed to Momordica 
charantia. (Sook et al, 2009). Momorcharin and 
momordicin (cytotoxic proteins) are also present. 
There are several methods in which Momordica 
charantia solutions are prepared. These include 
methanolic and aqueous extracts, of which the latter is 
more common. A large population that consumes the 
extract prepares large volumes and some kept for use 
the following day. In some communities, the excess 
solution is left in the open while in some higher income 
households it is refrigerated. Some populations boil the 
leaves while others use hot water infusion.  
Despite the numerous uses of Mormodica charantia 
aqueous leaf extract stored under various conditions, 
few studies have been carried out to investigate and 
compare their effect on myocardial rate and force of 
contraction.   
The current study was set out to compare the 
pharmacological effects of the various preparation and 
stored forms of Momordica charantia aqueous leaf 
extract on isolated mammalian heart. 
2. Materials and Methods 
2.1 Sample Collection and Preparation  
Fresh  leaves  of  Momordica  charantia  were  procured 
from  the  local  market  and  authenticated  by  the 
Department of Botany, University Of Nairobi. The leaves 
were assigned voucher number: JA2012/01. A voucher 
specimen was deposited in the herbarium.  
Preparation of fresh Momordica charantia aqueous 
leaf extract (sample 1) 
The leaves were air dried under the shade for three 
days.  The  dried  leaves  were  wrapped  in  water  proof 
paper  bags  and  stored  for  2  weeks  until  the  time  of 
extraction  (Bakare  et  al,  2011).  Extraction  of  the  
dried leaves  was  done  by  hot  infusion  using  20  ml  
of  hot water for every 1 g of leaf powder.  The extract 
was allowed to cool before filtering. 
Preparation of Refrigerated Momordica charantia 
aqueous leaf extract (sample 2) 
This was prepared by storing fresh Momordica 
charantia aqueous leaf extract in the fridge overnight 
and used the following day.  
Preparation of 24hr standing Momordica charantia 
aqueous leaf extract (sample 3) 
This was prepared by leaving fresh Momordica 
charantia aqueous leaf extract to stand overnight and 
used the following day.  
Preparation of boiled Momordica charantia aqueous 
leaf extract (sample 4) 
This was prepared by boiling dried Momordica 
charantia leaves for 5 minutes in water, in the ratio of 
20ml of water for every 1 gm. of leaf powder. The 
aqueous leaf extract was then filtered using Whattman 
filter paper number 1.  
2.2 Preparation of the physiological salt 
solution  
Tyrode’s solution was prepared using standard 
procedures. The composition of Tyrode’s solution was 
(g/L): Sodium chloride (8.0); Sodium bicarbonate (1.0); 
Glucose (1.0); Potassium chloride (0.2); Calcium 
chloride (0.2); Sodium dihydrogen phosphate (0.05); 
and Magnesium chloride (0.1).  During mixing, calcium 
chloride was dissolved separately in distilled water and 
added last to avoid precipitation.  The salts were 
manufactured by Muby Chemicals (India).  
2.3 Animal Husbandry 
New Zealand White rabbits were procured locally from 
Tony Rabbits and Guinea Pigs Farm (Kenya). They were 
housed in a clean environment in the animal house, 
Department of Medical Physiology. Standard laboratory 
conditions of humidity 50 ±15% and temperature of 25 
±20C, 12h/12h light-dark cycle was maintained.  They 
had free access to food and water. The procedures and 
experiments  were  performed  according  to  the 
guidelines  stated  by  the  Federation  of  European 
Laboratory Animal Science Associations (FELASA) 
(Adegu et al, 2014). 
2.4 Investigating effects of aqueous leaf extract 
on isolated heart  
Each rabbit was sacrificed by cervical dislocation.  The 
heart was removed and mounted on a Langendorff 
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apparatus.  Baseline myocardial rate and force of 
contraction was then recorded.  
Starting with the least volume, 0.2 ml (1 mg equivalent  
of  dried  leaf  powder)  of the  fresh  extract  was 
administered  by  infusion  into  the  aorta  and  the  
effects recorded.  The volume of the extract was 
successfully increased in 0.2 ml increments to a 
maximum of 1.0 ml. This was repeated 6 times. 
Thereafter, sample 2, 3 and 4 were each administered to 
a different isolated mammalian heart and changes in 
rate and force of contraction taken. Adrenaline (0.01 IU) 
was used as the positive control.  
Before  administration  of  each  of the doses, the 
perfusate was  allowed  to  wash  the  heart  for  10  
seconds  and baseline recordings taken. 
2.5 Data and statistical analysis 
Rate and strength of contraction was determined using 
the Langendorff apparatus. Data generated from the 
study was analyzed in terms of frequency and force of 
contraction. Frequency referred to the number of 
contractions per unit time while force referred to height 
of amplitude (in mm).  
The changes in rate and force of contraction were 
analyzed and expressed as Mean and Standard Error of 
Mean. Statistical analysis to find out whether there was 
significant change in rate and force of contraction after 
administration of the various dosages was done using 
Analysis of Variance (ANOVA) and unpaired t test.  Data 
analysis was done using Statistical Package for Social 
Sciences (SPSS version 17.0).  
Changes in rate and force of  contraction  after  
administration  of  the  various extracts was compared 
with baseline readings using unpaired sample t test 
with the p value set at p<0.05.   
2.6 Ethical considerations 
The animals that were used in the study  were handled 
with  care  as  the  welfare  of  the  laboratory  animals  
is important in influencing results. Moreover, the 
standard operating  procedures  (SOP)  of  the  
Department  of Medical  Physiology  animal  laboratory  
was  adhered  to.  
In addition to FELASA guidelines, the 3R principles 
(reduction, refinement and replacement) were adhered 
to. 
3.  Results  
Table 1 shows changes in rate and force  of  myocardial 
contraction   after  administration  of  various  doses  
and extracts.  There  was  a  significant  increase  in both  
the  force  and  rate  with  each  increase  in  dosage. 
However,  there  was  a  larger  increase  in  force  as 
compared  to  rate  of  contraction.  The increase in rate 
and force of contraction was directly proportional to the 
increase in the extract’s dose. This increase was 
statistically significant for both force and rate. The 
various P values are shown in Table 1. The largest 
magnitude of increase in rate and force of contraction 
was elicited by the boiled Momordica charantia aqueous 
leaf extract and least by the fresh extract. 
The effects of the extracts were however irreversible 
after wash out. 
Dose response effects of 24hr standing extract, 24hr 
fridge extract and fresh boiled fresh extract on 
myocardial force of contraction are shown in Figure 1. 
 
Table 1: Rate and force of contraction of the heart after administration of various concentrations of aqueous extract 
of Momordica charantia (N=6) 
Extract 
Conc. 
(mg/ml) 
Force of contraction (mm) 
(mean±SEM) 
 Frequency of contraction (per min) 
(mean±SEM) 
Baseline 
Sample 
1 
Sample 
2 
Sample 
3 
Sample 
4 
 
Baseline 
Sample 
1 
Sample 
2 
Sample 
3 
Sample 
4 
0.2 17.51 21±0.38 23±1.82 25±1.83 29±1.31  1.29 4.24±0.25 5.35±1.45 6.79±1.32 8.72±1.39 
0.4 17.82 34±1.36 37±1.39 39±1.42 41±1.93  1.63 6.53±0.36 9.79±1.76 10.86±1.79 12.96±1.47 
0.6 18.29 47±1.93 51±1.57 58±0.87 66±0.46  1.37 11.36±1.36 13.41±1.78 15.57±1.39 17.18±1.09 
0.8 19.73 51±1.37 58±1.79 63±1.78 71±1.45  1.38 15.46±1.97 16.31±1.79 19.46±1.73 23.32±0.31 
1.0 19.43 63±1.31 71±1.35 77±1.41 89±1.89  1.89 19.57±1.08 22.68±1.84 24.53±1.02 27.21±1.04 
P Value  0.023 0.021 0.017 <0.001   0.023 0.014 0.008 <0.0001 
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Figure 1: Mean percentage changes in force of myocardial contraction after administration of 3 different samples 
 
Figure 2: Mean percentage changes in myocardial rate of contraction after administration of 3 different extracts 
 
4 Discussion 
There was a pattern of increase in force and rate of 
contraction after the administration of the various 
doses of the fresh, 24hr open extract, refrigerated 
extract and boiled extract. The lag time decreased as the 
doses were increased, while the gradient showing 
change in rate and force of contraction increased as the 
doses were increased.  
The gradient showing change in rate and force of 
contraction increased as the doses increased because as 
the doses were increased, it provided a large number of 
agonists (phytochemicals responsible for the extract’s 
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actions) binding to a larger number of receptors per 
unit time therefore bringing about larger changes in 
rate and force of contraction per unit time. The effects 
of the extract were however irreversible after wash out. 
The irreversibility of the effects could indicate that the 
extract binds permanently to receptors involved. 
The reason as to why the change in force and rate of 
contraction for the same extract dose was highest in the 
boiled sample was most probable due to concentration 
of phytochemicals by boiling. It could as well be due to 
the enhanced extraction of the active phytochemicals 
(agonists) by boiling. This increased its potency. For the 
24 hr. extract that was left in the open, it probably 
underwent degradation and other chemical changes 
that could have slightly enhanced its potency against 
the fresh aqueous extract. The degradation process 
could have been precipitated by the microorganisms 
present in the air. The 24 hr. fridge extract was less 
potent than the 24 hr. room temperature extract 
because most probably the lower temperatures in the 
fridge slowed down the degradation process of the 
active ingredients into more toxic compounds. The 
significant differences in gradients showing change of 
force and rate of contraction after the administration of 
same dose of boiled, 24 hr. room temperature and 24 
hr. fridge extract is a further indication that the boiled 
extract is the most highly potent than the open and 
fridge extracts respectively. 
5. Conclusion 
The present study shows Momordica charantia aqueous 
leaf extract stored in various conditions and or 
prepared differently have an effect on myocardial rate 
and force of contraction. It has further demonstrated 
that the extract increases both myocardial force and 
rate of contraction. The increase is dose depended and 
is further supported by the tests of significance. It also 
determined that boiled Momordica charantia aqueous 
leaf extract has the largest effect on myocardial rate and 
force of contraction. 
The present study did not seek to establish toxic levels 
of the various extract doses but recommends further 
studies to establish toxic levels be undertaken. The 
researcher also recommends that for a targeted effect, 
the prescriber of the extract should indicate dosages 
based on the method of extract preparation and storage, 
as they exhibit different potencies. 
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